Kymera Therapeutics (KYMR) EBITDA Margin (QoQ) (2019 - 2026)
Kymera Therapeutics (KYMR) EBITDA Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,613.00 |
| Dec 31, 2025 | -6,365.00 |
| Sep 30, 2025 | -261,054.00 |
| Jun 30, 2025 | -40,005.00 |
| Mar 31, 2025 | 75,540.00 |
| Dec 31, 2024 | 83,576.00 |
| Sep 30, 2024 | -172,940.00 |
| Jun 30, 2024 | 36,364.00 |
| Mar 31, 2024 | -52,185.00 |
| Dec 31, 2023 | 117,602.00 |
| Sep 30, 2023 | -95,363.00 |
| Jun 30, 2023 | 21,611.00 |
| Mar 31, 2023 | -23,947.00 |
| Dec 31, 2022 | 23,056.00 |
| Sep 30, 2022 | -11,548.00 |
| Jun 30, 2022 | 2,940.00 |
| Mar 31, 2022 | -16,129.00 |
| Dec 31, 2021 | -8,173.00 |
| Sep 30, 2021 | -728.00 |
| Jun 30, 2021 | -6,312.00 |